Hsu, Y.-L.; Chen, H.-J.; Gao, J.-X.; Yang, M.-Y.; Fu, R.-H.
Chiisanoside Mediates the Parkin/ZNF746/PGC-1α Axis by Downregulating MiR-181a to Improve Mitochondrial Biogenesis in 6-OHDA-Caused Neurotoxicity Models In Vitro and In Vivo: Suggestions for Prevention of Parkinson’s Disease. Antioxidants 2023, 12, 1782.
https://doi.org/10.3390/antiox12091782
AMA Style
Hsu Y-L, Chen H-J, Gao J-X, Yang M-Y, Fu R-H.
Chiisanoside Mediates the Parkin/ZNF746/PGC-1α Axis by Downregulating MiR-181a to Improve Mitochondrial Biogenesis in 6-OHDA-Caused Neurotoxicity Models In Vitro and In Vivo: Suggestions for Prevention of Parkinson’s Disease. Antioxidants. 2023; 12(9):1782.
https://doi.org/10.3390/antiox12091782
Chicago/Turabian Style
Hsu, Yu-Ling, Hui-Jye Chen, Jia-Xin Gao, Ming-Yang Yang, and Ru-Huei Fu.
2023. "Chiisanoside Mediates the Parkin/ZNF746/PGC-1α Axis by Downregulating MiR-181a to Improve Mitochondrial Biogenesis in 6-OHDA-Caused Neurotoxicity Models In Vitro and In Vivo: Suggestions for Prevention of Parkinson’s Disease" Antioxidants 12, no. 9: 1782.
https://doi.org/10.3390/antiox12091782
APA Style
Hsu, Y.-L., Chen, H.-J., Gao, J.-X., Yang, M.-Y., & Fu, R.-H.
(2023). Chiisanoside Mediates the Parkin/ZNF746/PGC-1α Axis by Downregulating MiR-181a to Improve Mitochondrial Biogenesis in 6-OHDA-Caused Neurotoxicity Models In Vitro and In Vivo: Suggestions for Prevention of Parkinson’s Disease. Antioxidants, 12(9), 1782.
https://doi.org/10.3390/antiox12091782
